Cubist Systematic Strategies, LLC Verve Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 678,625 shares of VERV stock, worth $3.92 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

678,625

Previous 395,699 71.5%

Holding current value

$3.92 Million

Previous $1.93 Million 70.07%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.4 - $7.86 $1.24 Million - $2.22 Million	282,926 Added 71.5%	678,625 $3.28 Million
Q2 2024 Aug 14, 2024	BUY	$4.76 - $12.79 $1.34 Million - $3.6 Million	281,173 Added 245.51%	395,699 $1.93 Million
Q1 2024 May 15, 2024	SELL	$10.81 - $17.96 $317,889 - $528,149	-29,407 Reduced 20.43%	114,526 $1.52 Million
Q4 2023 Feb 14, 2024	BUY	$8.84 - $18.7 $240,757 - $509,294	27,235 Added 23.34%	143,933 $2.01 Million
Q3 2023 Nov 14, 2023	BUY	$11.42 - $20.82 $892,370 - $1.63 Million	78,141 Added 202.66%	116,698 $1.55 Million
Q2 2023 Aug 14, 2023	SELL	$13.34 - $19.9 $1.73 Million - $2.58 Million	-129,569 Reduced 77.07%	38,557 $722,000
Q1 2023 May 15, 2023	BUY	$14.3 - $24.01 $1.59 Million - $2.67 Million	111,004 Added 194.33%	168,126 $2.42 Million
Q4 2022 Feb 14, 2023	BUY	$17.85 - $40.7 $659,307 - $1.5 Million	36,936 Added 182.98%	57,122 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$15.63 - $41.49 $1.66 Million - $4.4 Million	-105,943 Reduced 84.0%	20,186 $693,000
Q2 2022 Aug 15, 2022	BUY	$11.14 - $23.17 $1.13 Million - $2.36 Million	101,663 Added 415.53%	126,129 $1.93 Million
Q1 2022 May 16, 2022	BUY	$20.92 - $39.36 $511,828 - $962,981	24,466 New	24,466 $558,000
Q4 2021 Feb 14, 2022	SELL	$31.94 - $54.82 $204,607 - $351,176	-6,406 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$46.0 - $73.99 $278,530 - $448,009	6,055 Added 1725.07%	6,406 $301,000
Q2 2021 Aug 16, 2021	BUY	$31.92 - $60.25 $11,203 - $21,147	351 New	351 $21,000

Others Institutions Holding VERV

# of Institutions

186

Shares Held

73.3M

Call Options Held

85K

Put Options Held

215K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $346M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Verve Therapeutics, Inc. Transaction History